UniProt ID | VASP_HUMAN | |
---|---|---|
UniProt AC | P50552 | |
Protein Name | Vasodilator-stimulated phosphoprotein | |
Gene Name | VASP | |
Organism | Homo sapiens (Human). | |
Sequence Length | 380 | |
Subcellular Localization | Cytoplasm. Cytoplasm, cytoskeleton. Cell junction, focal adhesion. Cell junction, tight junction. Cell projection, lamellipodium membrane. Cell projection, filopodium membrane. Targeted to stress fibers and focal adhesions through interaction with a | |
Protein Description | Ena/VASP proteins are actin-associated proteins involved in a range of processes dependent on cytoskeleton remodeling and cell polarity such as axon guidance, lamellipodial and filopodial dynamics, platelet activation and cell migration. VASP promotes actin filament elongation. It protects the barbed end of growing actin filaments against capping and increases the rate of actin polymerization in the presence of capping protein. VASP stimulates actin filament elongation by promoting the transfer of profilin-bound actin monomers onto the barbed end of growing actin filaments. Plays a role in actin-based mobility of Listeria monocytogenes in host cells. Regulates actin dynamics in platelets and plays an important role in regulating platelet aggregation.. | |
Protein Sequence | MSETVICSSRATVMLYDDGNKRWLPAGTGPQAFSRVQIYHNPTANSFRVVGRKMQPDQQVVINCAIVRGVKYNQATPNFHQWRDARQVWGLNFGSKEDAAQFAAGMASALEALEGGGPPPPPALPTWSVPNGPSPEEVEQQKRQQPGPSEHIERRVSNAGGPPAPPAGGPPPPPGPPPPPGPPPPPGLPPSGVPAAAHGAGGGPPPAPPLPAAQGPGGGGAGAPGLAAAIAGAKLRKVSKQEEASGGPTAPKAESGRSGGGGLMEEMNAMLARRRKATQVGEKTPKDESANQEEPEARVPAQSESVRRPWEKNSTTLPRMKSSSSVTTSETQPCTPSSSDYSDLQRVKQELLEEVKKELQKVKEEIIEAFVQELRKRGSP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MSETVICSS ------CCCEEEECC | 41.81 | 19413330 | |
2 | Phosphorylation | ------MSETVICSS ------CCCEEEECC | 41.81 | 30108239 | |
4 | Phosphorylation | ----MSETVICSSRA ----CCCEEEECCCC | 14.09 | 30108239 | |
8 | Phosphorylation | MSETVICSSRATVML CCCEEEECCCCEEEE | 16.25 | - | |
14 | Sulfoxidation | CSSRATVMLYDDGNK ECCCCEEEEEECCCE | 2.20 | 30846556 | |
16 | Phosphorylation | SRATVMLYDDGNKRW CCCEEEEEECCCEEE | 8.22 | 25839225 | |
21 | Acetylation | MLYDDGNKRWLPAGT EEEECCCEEEEECCC | 50.94 | 26051181 | |
39 | Phosphorylation | AFSRVQIYHNPTANS CCCEEEEECCCCCCC | 4.39 | 21945579 | |
43 | Phosphorylation | VQIYHNPTANSFRVV EEEECCCCCCCEEEE | 43.73 | 21945579 | |
46 | Phosphorylation | YHNPTANSFRVVGRK ECCCCCCCEEEEEEC | 16.38 | 21945579 | |
68 | Methylation | VINCAIVRGVKYNQA EEEEEEECCCCCCCC | 37.77 | 115385805 | |
71 | Ubiquitination | CAIVRGVKYNQATPN EEEECCCCCCCCCCC | 41.11 | 21890473 | |
71 | Malonylation | CAIVRGVKYNQATPN EEEECCCCCCCCCCC | 41.11 | 26320211 | |
71 | Acetylation | CAIVRGVKYNQATPN EEEECCCCCCCCCCC | 41.11 | 26051181 | |
76 | Phosphorylation | GVKYNQATPNFHQWR CCCCCCCCCCCHHHH | 14.70 | 25690035 | |
126 | Phosphorylation | PPPPALPTWSVPNGP CCCCCCCCCCCCCCC | 31.08 | 28348404 | |
134 | Phosphorylation | WSVPNGPSPEEVEQQ CCCCCCCCHHHHHHH | 46.47 | 28348404 | |
157 | Phosphorylation | EHIERRVSNAGGPPA HHHHHHHHCCCCCCC | 21.10 | 23927012 | |
239 | Phosphorylation | GAKLRKVSKQEEASG HHHHHHHHCCHHHCC | 31.49 | 23927012 | |
240 | Acetylation | AKLRKVSKQEEASGG HHHHHHHCCHHHCCC | 65.79 | 26051181 | |
245 | Phosphorylation | VSKQEEASGGPTAPK HHCCHHHCCCCCCCC | 47.78 | 23403867 | |
249 | Phosphorylation | EEASGGPTAPKAESG HHHCCCCCCCCHHCC | 59.89 | 23927012 | |
252 | Acetylation | SGGPTAPKAESGRSG CCCCCCCCHHCCCCC | 63.42 | 7683629 | |
255 | Phosphorylation | PTAPKAESGRSGGGG CCCCCHHCCCCCCCH | 44.35 | 30576142 | |
258 | Phosphorylation | PKAESGRSGGGGLME CCHHCCCCCCCHHHH | 45.36 | 22199227 | |
264 | Sulfoxidation | RSGGGGLMEEMNAML CCCCCHHHHHHHHHH | 4.66 | 21406390 | |
276 | Acetylation | AMLARRRKATQVGEK HHHHHHHHHHHCCCC | 54.71 | 26051181 | |
278 | Phosphorylation | LARRRKATQVGEKTP HHHHHHHHHCCCCCC | 27.16 | 8182057 | |
283 | Acetylation | KATQVGEKTPKDESA HHHHCCCCCCCCCCC | 65.29 | 19608861 | |
284 | Phosphorylation | ATQVGEKTPKDESAN HHHCCCCCCCCCCCC | 31.13 | 23401153 | |
286 | Sumoylation | QVGEKTPKDESANQE HCCCCCCCCCCCCCC | 78.38 | - | |
286 | Sumoylation | QVGEKTPKDESANQE HCCCCCCCCCCCCCC | 78.38 | - | |
289 | Phosphorylation | EKTPKDESANQEEPE CCCCCCCCCCCCCCC | 42.53 | 25159151 | |
303 | Phosphorylation | EARVPAQSESVRRPW CCCCCCCCHHCCCCC | 33.67 | 23401153 | |
305 | Phosphorylation | RVPAQSESVRRPWEK CCCCCCHHCCCCCCC | 26.60 | 23401153 | |
312 | Ubiquitination | SVRRPWEKNSTTLPR HCCCCCCCCCCCCCC | 52.94 | - | |
314 | Phosphorylation | RRPWEKNSTTLPRMK CCCCCCCCCCCCCCC | 33.56 | 23401153 | |
315 | Phosphorylation | RPWEKNSTTLPRMKS CCCCCCCCCCCCCCC | 41.57 | 23401153 | |
316 | Phosphorylation | PWEKNSTTLPRMKSS CCCCCCCCCCCCCCC | 34.29 | 26846344 | |
321 | Ubiquitination | STTLPRMKSSSSVTT CCCCCCCCCCCCCCC | 48.76 | - | |
321 | Methylation | STTLPRMKSSSSVTT CCCCCCCCCCCCCCC | 48.76 | 115978835 | |
322 | Phosphorylation | TTLPRMKSSSSVTTS CCCCCCCCCCCCCCC | 26.55 | 22167270 | |
323 | Phosphorylation | TLPRMKSSSSVTTSE CCCCCCCCCCCCCCC | 22.55 | 22167270 | |
324 | Phosphorylation | LPRMKSSSSVTTSET CCCCCCCCCCCCCCC | 35.60 | 22167270 | |
325 | Phosphorylation | PRMKSSSSVTTSETQ CCCCCCCCCCCCCCC | 25.98 | 22167270 | |
327 | Phosphorylation | MKSSSSVTTSETQPC CCCCCCCCCCCCCCC | 26.93 | 22167270 | |
328 | Phosphorylation | KSSSSVTTSETQPCT CCCCCCCCCCCCCCC | 23.55 | 23927012 | |
329 | Phosphorylation | SSSSVTTSETQPCTP CCCCCCCCCCCCCCC | 29.31 | 23927012 | |
331 | Phosphorylation | SSVTTSETQPCTPSS CCCCCCCCCCCCCCC | 37.26 | 23927012 | |
335 | Phosphorylation | TSETQPCTPSSSDYS CCCCCCCCCCCCCHH | 32.65 | 27273156 | |
337 | Phosphorylation | ETQPCTPSSSDYSDL CCCCCCCCCCCHHHH | 25.07 | 23927012 | |
338 | Phosphorylation | TQPCTPSSSDYSDLQ CCCCCCCCCCHHHHH | 28.56 | 28152594 | |
339 | Phosphorylation | QPCTPSSSDYSDLQR CCCCCCCCCHHHHHH | 44.92 | 28152594 | |
341 | Phosphorylation | CTPSSSDYSDLQRVK CCCCCCCHHHHHHHH | 13.16 | 23927012 | |
342 | Phosphorylation | TPSSSDYSDLQRVKQ CCCCCCHHHHHHHHH | 36.51 | 28152594 | |
348 | Ubiquitination | YSDLQRVKQELLEEV HHHHHHHHHHHHHHH | 40.00 | - | |
348 | Acetylation | YSDLQRVKQELLEEV HHHHHHHHHHHHHHH | 40.00 | 26051181 | |
356 | Acetylation | QELLEEVKKELQKVK HHHHHHHHHHHHHHH | 43.75 | 26051181 | |
363 | Ubiquitination | KKELQKVKEEIIEAF HHHHHHHHHHHHHHH | 57.58 | 21890473 | |
363 | Acetylation | KKELQKVKEEIIEAF HHHHHHHHHHHHHHH | 57.58 | 26051181 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
39 | Y | Phosphorylation | Kinase | ALK | Q9UM73 | PSP |
157 | S | Phosphorylation | Kinase | PKG/CGK_GROUP | - | PhosphoELM |
157 | S | Phosphorylation | Kinase | PKA | - | Uniprot |
157 | S | Phosphorylation | Kinase | PKG-FAMILY | - | GPS |
157 | S | Phosphorylation | Kinase | PKC-FAMILY | - | GPS |
157 | S | Phosphorylation | Kinase | PKC | - | Uniprot |
157 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
157 | S | Phosphorylation | Kinase | ROCK1 | Q13464 | Uniprot |
157 | S | Phosphorylation | Kinase | PRKD2 | Q9BZL6 | PSP |
157 | S | Phosphorylation | Kinase | PRKD1 | Q15139 | PSP |
157 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
157 | S | Phosphorylation | Kinase | PKG1 | Q13976 | PSP |
157 | S | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
157 | S | Phosphorylation | Kinase | PRKG1 | P00516 | GPS |
157 | S | Phosphorylation | Kinase | PRKACA | P00517 | GPS |
157 | S | Phosphorylation | Kinase | PKACA | P17612 | PSP |
239 | S | Phosphorylation | Kinase | PKG-FAMILY | - | GPS |
239 | S | Phosphorylation | Kinase | PKG1 | Q13976 | PSP |
239 | S | Phosphorylation | Kinase | PRKACA | P00517 | GPS |
239 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
239 | S | Phosphorylation | Kinase | PKACA | P17612 | PSP |
239 | S | Phosphorylation | Kinase | PKA | - | Uniprot |
239 | S | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
239 | S | Phosphorylation | Kinase | PRKD2 | Q9BZL6 | PSP |
239 | S | Phosphorylation | Kinase | PKG/CGK_GROUP | - | PhosphoELM |
239 | S | Phosphorylation | Kinase | PRKG1 | P00516 | GPS |
278 | T | Phosphorylation | Kinase | PKA | - | Uniprot |
278 | T | Phosphorylation | Kinase | PKG/CGK_GROUP | - | PhosphoELM |
278 | T | Phosphorylation | Kinase | RPS6KA1 | Q15418 | GPS |
278 | T | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
278 | T | Phosphorylation | Kinase | PKG-FAMILY | - | GPS |
278 | T | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
278 | T | Phosphorylation | Kinase | AMPK-FAMILY | - | GPS |
278 | T | Phosphorylation | Kinase | AMPK | Q9Y478 | Uniprot |
278 | T | Phosphorylation | Kinase | PKG1 | Q13976 | PSP |
278 | T | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
278 | T | Phosphorylation | Kinase | PRKAA1 | Q13131 | GPS |
322 | S | Phosphorylation | Kinase | PRKD2 | Q9BZL6 | PSP |
322 | S | Phosphorylation | Kinase | PRKD1 | Q15139 | PSP |
322 | S | Phosphorylation | Kinase | AMPK | Q9Y478 | Uniprot |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
157 | S | Phosphorylation |
| 8182057 |
157 | S | Phosphorylation |
| 8182057 |
157 | S | Phosphorylation |
| 8182057 |
157 | S | Phosphorylation |
| 8182057 |
157 | S | Phosphorylation |
| 8182057 |
157 | S | Phosphorylation |
| 8182057 |
239 | S | Phosphorylation |
| 8182057 |
239 | S | Phosphorylation |
| 8182057 |
239 | S | Phosphorylation |
| 8182057 |
239 | S | Phosphorylation |
| 8182057 |
278 | T | Phosphorylation |
| 8182057 |
278 | T | Phosphorylation |
| 8182057 |
322 | S | Phosphorylation |
| 18669648 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of VASP_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Exploring proteomes and analyzing protein processing by massspectrometric identification of sorted N-terminal peptides."; Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,Thomas G.R., Vandekerckhove J.; Nat. Biotechnol. 21:566-569(2003). Cited for: PROTEIN SEQUENCE OF 2-10, AND ACETYLATION AT SER-2. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-283, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-316 AND SER-322, ANDMASS SPECTROMETRY. | |
"Carbon monoxide and nitric oxide mediate cytoskeletal reorganizationin microvascular cells via vasodilator-stimulated phosphoproteinphosphorylation: evidence for blunted responsiveness in diabetes."; Li Calzi S., Purich D.L., Chang K.H., Afzal A., Nakagawa T.,Busik J.V., Agarwal A., Segal M.S., Grant M.B.; Diabetes 57:2488-2494(2008). Cited for: FUNCTION, SUBCELLULAR LOCATION, AND PHOSPHORYLATION AT SER-157 ANDSER-239. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-239, AND MASSSPECTROMETRY. | |
"Vasodilator-stimulated phosphoprotein (VASP) is phosphorylated on Ser157 by protein kinase C-dependent and -independent mechanisms inthrombin-stimulated human platelets."; Wentworth J.K., Pula G., Poole A.W.; Biochem. J. 393:555-564(2006). Cited for: PHOSPHORYLATION AT SER-157, AND SUBCELLULAR LOCATION. | |
"Phosphorylation of focal adhesion vasodilator-stimulatedphosphoprotein at Ser157 in intact human platelets correlates withfibrinogen receptor inhibition."; Horstrup K., Jablonka B., Honig-Liedl P., Just M., Kochsiek K.,Walter U.; Eur. J. Biochem. 225:21-27(1994). Cited for: PHOSPHORYLATION AT SER-157, AND FIBRINOGEN RECEPTOR INHIBITION. | |
"cAMP- and cGMP-dependent protein kinase phosphorylation sites of thefocal adhesion vasodilator-stimulated phosphoprotein (VASP) in vitroand in intact human platelets."; Butt E., Abel K., Krieger M., Palm D., Hoppe V., Hoppe J., Walter U.; J. Biol. Chem. 269:14509-14517(1994). Cited for: PROTEIN SEQUENCE OF 143-164; 235-244 AND 267-285, AND PHOSPHORYLATIONAT SER-157; SER-239 AND THR-278 BY PRKG1. | |
"AMP-activated protein kinase impairs endothelial actin cytoskeletonassembly by phosphorylating vasodilator-stimulated phosphoprotein."; Blume C., Benz P.M., Walter U., Ha J., Kemp B.E., Renne T.; J. Biol. Chem. 282:4601-4612(2007). Cited for: PHOSPHORYLATION AT THR-278, MUTAGENESIS OF SER-157; SER-239 ANDTHR-278, AND FUNCTION. | |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-39, AND MASSSPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-39, AND MASSSPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-39, AND MASSSPECTROMETRY. |